Results 111 to 120 of about 1,108 (148)
SIRT7基因低表达胶质瘤细胞株代谢特征的NMR分析 [PDF]
肿瘤是一种代谢疾病,癌基因表达对肿瘤细胞代谢的影响是目前肿瘤研究的热点之一.本文利用基于核磁共振氢谱(~1H NMR)的代谢组学方法对癌基因SIRT7低表达胶质瘤细胞株的代谢特征进行分析,寻找与SIRT7基因表达相关的特征性代谢物和代谢通路.分析结果表明,SIRT7基因低表达组与对照组细胞的代谢轮廓存在显著性差异,其细胞水溶性萃取物中有22种代谢物浓度发生明显变化.与对照组相比,SIRT7基因低表达胶质瘤细胞株中乳酸、甘氨酸、谷氨酸等12种代谢物浓度升高;缬氨酸、亮氨酸、赖氨酸等10种代谢物浓度降低 ...
林清源 +4 more
core
NRF2 has been recognized as a central hub that neutralizes ROS and restores intracellular redox balance. In addition to KEAP1 mediated ubiquitin-proteasome degradation, post-translational modifications of NRF2 are critical for regulating its nuclear ...
Tingzi Yu +6 more
doaj +1 more source
YZL-51N functions as a selective inhibitor of SIRT7 by NAD+ competition to impede DNA damage repair
Summary: The NAD+-dependent deacetylase SIRT7 is a pivotal regulator of DNA damage response (DDR) and a promising drug target for developing cancer therapeutics. However, limited progress has been made in SIRT7 modulator discovery.
Tian-Shu Kang +13 more
doaj +1 more source
Pancreatic neuroendocrine tumors (PanNETs) frequently exhibit loss or reduced expression of the tumor suppressor MEN1, a key regulator of tumor progression and DNA damage response (DDR).
Jianyun Jiang +11 more
doaj +1 more source
Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells
Cisplatin (CDDP) resistance has been established to significantly impact Bladder Cancer (BCa) therapy. On the other hand, the crucial regulatory involvement of SIRT7 and EZH2 in bladder cancer development is well known.
Yudong Cao +11 more
doaj +1 more source
The SIRT7-nucleolus connection in cancer
The nucleolar enzyme sirtuin 7 (SIRT7) promotes cancer progression in certain malignancies, likely in part by controlling ribosome biosynthesis. Recently, we discovered that SIRT7 destabilizes the cyclin dependent kinase inhibitor 2A (CDKN2A, known as ARF) within the nucleolus, aiding cancer progression. We propose that targeting nucleolar SIRT7 offers
Tarighi, S. +4 more
openaire +1 more source

